Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
Locations
  • Massachusetts General Hospital . Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Newly Diagnosed Glioblastoma

NCT04959500

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Beijing TianTan Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • The Sixth Madical Center of PLA General Hospital Beijing, Beijing Municipality, China
  • The General Hospital of the People's Liberation Army (PLAGH) Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Active, Not Recruiting

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

NCT03161431

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • University of Miami Miami, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Post-Authorization Long-Term Safety Study of LUTATHERA

NCT03691064

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Banner MD Anderson Cancer Center Phoenix, Arizona, United States
  • The Ohio State University Wexner Medical Center Portland, Ohio, United States
  • Oregon Health & Sciences University Hospital Portland, Oregon, United States
  • Virginia Mason in Seattle Seattle, Washington, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details

Related conditions